Skip to main content
. 2014 May 14;10:355–362. doi: 10.2147/TCRM.S47632

Figure 1.

Figure 1

Pathophysiologic changes during a malignant hyperthermia crisis.

Abbreviations: Ca2+, calcium; DHP receptor, dihydropyridine receptor; MH, malignant hyperthermia; RYR1, ryanodine receptor subtype 1.